scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0168-8278(03)00217-4 |
P698 | PubMed publication ID | 12873823 |
P50 | author | Massimo Iavarone | Q56850282 |
Dina Kremsdorf | Q87134290 | ||
P2093 | author name string | Massimo Colombo | |
Christian Bréchot | |||
Valérie Thiers | |||
Françoise Carnot | |||
Oona Delpuech | |||
Jean-Baptiste Trabut | |||
P2860 | cites work | Laser capture microdissection | Q28293867 |
Multiple mutation analyses in single tumor cells with improved whole genome amplification | Q31920327 | ||
Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls | Q33765576 | ||
Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). | Q33998195 | ||
Hepatitis B virus and hepatocellular carcinoma | Q34308890 | ||
The hepatitis B virus X gene induces p53-mediated programmed cell death | Q36303449 | ||
Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis | Q36830710 | ||
Whole genome amplification from a single cell: implications for genetic analysis | Q37081188 | ||
X-gene product of hepatitis B virus induces apoptosis in liver cells | Q41067693 | ||
Precore and core promoter mutations, hepatitis B virus DNA levels and progressive liver injury in chronic hepatitis B. | Q45731371 | ||
Expression of integrated hepatitis B virus X variants in human hepatocellular carcinomas and its significance | Q45740225 | ||
Hepatitis B virus X gene variability in French-born patients with chronic hepatitis and hepatocellular carcinoma | Q45740490 | ||
Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. | Q45747173 | ||
Clinical implications of mutations C-to-T1653 and T-to-C/A/G1753 of hepatitis B virus genotype C genome in chronic liver disease | Q45747338 | ||
High prevalence of 1762(T) 1764(A) mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers. | Q45751000 | ||
Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: comparative analysis of 40 full-length isolates | Q45751517 | ||
p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro | Q45753041 | ||
Deletion mutants of the hepatitis B virus X gene in human hepatocellular carcinoma | Q45758419 | ||
Hot-spot mutations in hepatitis B virus X gene in hepatocellular carcinoma | Q45768755 | ||
HBx gene of hepatitis B virus induces liver cancer in transgenic mice | Q45852802 | ||
Direct cloning and sequence analysis of enzymatically amplified genomic sequences | Q68732880 | ||
P433 | issue | 2 | |
P921 | main subject | microdissection | Q4293202 |
Hepatitis B virus | Q6844 | ||
hepatitis B | Q6853 | ||
P304 | page(s) | 253-261 | |
P577 | publication date | 2003-08-01 | |
P1433 | published in | Journal of Hepatology | Q15724402 |
P1476 | title | Characterisation of hepatitis B virus X protein mutants in tumour and non-tumour liver cells using laser capture microdissection | |
P478 | volume | 39 |
Q37728191 | A mutant of HBx (HBxDelta127) promotes hepatoma cell growth via sterol regulatory element binding protein 1c involving 5-lipoxygenase |
Q37728807 | A mutant of hepatitis B virus X protein (HBx Delta 127) enhances hepatoma cell migration via osteopontin involving 5-lipoxygenase |
Q33622555 | A mutant of hepatitis B virus X protein (HBxDelta127) promotes cell growth through a positive feedback loop involving 5-lipoxygenase and fatty acid synthase |
Q37068909 | A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines |
Q44268693 | Analysis of hepatitis B virus X gene phylogeny, genetic variability and its impact on pathogenesis: implications in Eastern Indian HBV carriers |
Q55395370 | Applications of next-generation sequencing analysis for the detection of hepatocellular carcinoma-associated hepatitis B virus mutations. |
Q44956160 | Association of human APOBEC3 cytidine deaminases with the generation of hepatitis virus B x antigen mutants and hepatocellular carcinoma |
Q36451722 | Basal core promoter mutation is associated with progression to cirrhosis rather than hepatocellular carcinoma in chronic hepatitis B virus infection |
Q37538538 | C-terminal-truncated HBV X promotes hepato-oncogenesis through inhibition of tumor-suppressive β-catenin/BAMBI signaling |
Q37220648 | COOH-terminal deletion of HBx gene is a frequent event in HBV-associated hepatocellular carcinoma |
Q33988586 | Carboxyl-terminal truncated HBx regulates a distinct microRNA transcription program in hepatocellular carcinoma development |
Q33801311 | Clinical implications of hepatitis B virus mutations: recent advances |
Q33764377 | Contribution of laser microdissection-based technology to proteomic analysis in hepatocellular carcinoma developing on cirrhosis |
Q34177169 | Cooperation of tumor-derived HBx mutants and p53-249(ser) mutant in regulating cell proliferation, anchorage-independent growth and aneuploidy in a telomerase-immortalized normal human hepatocyte-derived cell line |
Q42615096 | Distinct mutant hepatitis B virus genomes, with alterations in all four open reading frames, in a single South African hepatocellular carcinoma patient. |
Q90416073 | Epigenetic modulation in chronic hepatitis B virus infection |
Q26772348 | Genetic variation of hepatitis B virus and its significance for pathogenesis |
Q35507447 | Genotypes, mutations, and viral load of hepatitis B virus and the risk of hepatocellular carcinoma: HBV properties and hepatocarcinogenesis. |
Q41100060 | HBx truncation mutants differentially modulate SREBP-1a and -1c transcription and HBV replication |
Q26744503 | Hepatitis B Virus X Protein and Hepatocarcinogenesis |
Q47136720 | Hepatitis B virus (HBV) X gene mutations and their association with liver disease progression in HBV-infected patients |
Q37776350 | Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC): Molecular mechanisms and novel paradigms |
Q37885837 | Hepatitis B virus X gene and hepatocarcinogenesis. |
Q37621008 | Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis |
Q38110262 | Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis |
Q40893329 | Hepatitis B virus full-length genomic mutations and quasispecies in hepatocellular carcinoma |
Q35663838 | Hepatitis B virus genotypes and variants. |
Q27024874 | Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma |
Q36519025 | Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis |
Q37888329 | Hepatocellular carcinoma: the point of view of the hepatitis B virus |
Q45404616 | Impact of hepatitis B virus basic core promoter mutations on T cell response to an immunodominant HBx-derived epitope |
Q28649881 | Integration of tumour and viral genomic characterizations in HBV-related hepatocellular carcinomas |
Q26782044 | Molecular mechanism of hepatitis B virus X protein function in hepatocarcinogenesis |
Q36743649 | Mutations in the C-terminus of the X protein of hepatitis B virus regulate Wnt-5a expression in hepatoma Huh7 cells: cDNA microarray and proteomic analyses |
Q33833014 | Natural variants of hepatitis B virus X protein have differential effects on the expression of cyclin-dependent kinase inhibitor p21 gene |
Q34124107 | Novel type of hepatitis B virus mutation: replacement mutation involving a hepatocyte nuclear factor 1 binding site tandem repeat in chronic hepatitis B virus genotype E. |
Q104570091 | Partial abrogation of FXR-KNG1 signaling by carboxyl-terminal truncated HBx-C30 in hepatitis B virus-associated hepatocellular carcinoma |
Q33925491 | Pathogenesis of hepatitis B virus infection |
Q45420734 | Prognostic analysis in chronic hepatitis B patients: a retrospective study of 216 cases about Scheuer scores, in situ expression of viral antigens and tissue hepatitis B virus DNA levels |
Q34389406 | Retracted: The Effect of miR-338-3p on HBx Deletion-Mutant (HBx-d382) Mediated Liver-Cell Proliferation through CyclinD1 Regulation |
Q38056849 | Tackling hepatitis B virus-associated hepatocellular carcinoma--the future is now. |
Q41272310 | Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis. |
Q40209037 | Unexpected mosaicism of R201H-GNAS1 mutant-bearing cells in the testes underlie macro-orchidism without sexual precocity in McCune-Albright syndrome |
Search more.